Chromocell Therapeutics Corp (CHRO) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 11 transactions totaling $125.8K, demonstrating a bullish sentiment with $125.8K in net insider flow. The most recent transaction on Sep 13, 2024 involved a purchase of 3,500 shares valued at $3.4K.
No significant insider buying has been recorded for CHRO in the recent period.
No significant insider selling has been recorded for CHRO in the recent period.
Based on recent SEC filings, insider sentiment for CHRO is bullish with an Insider Alignment Score of 100/100 and a net flow of $125.8K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Chromocell Therapeutics Corp (CHRO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading CHRO stock, having executed 11 transactions in the past 90 days. The most active insider is Ezra M. Friedberg (Executive), who has made 3 transactions totaling $199.1K.
Get notified when executives and directors at CHRO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Francis Knuettel II | Executive | Purchase | 3,500 | $0.97 | $3.4K | |
| Sep 12, 2024 | Francis Knuettel II | Executive | Purchase | 1,700 | $0.97 | $1.6K | |
| Sep 12, 2024 | Malamut Richard | Executive | Purchase | 10,400 | $0.94 | $9.8K | |
| Sep 11, 2024 | Francis Knuettel II | Executive | Purchase | 5,500 | $0.94 | $5.2K | |
| Sep 10, 2024 | Francis Knuettel II | Executive | Purchase | 6,500 | $0.89 | $5.8K | |
| Jun 28, 2024 | Francis Knuettel II | Executive | Gift | 15,000 | $N/A | $0 | |
| Jun 28, 2024 | Francis Knuettel II | Executive | Gift | 5,000 | $N/A | $0 | |
| Feb 21, 2024 | M. Friedberg Ezra | Executive | Option Exercise | 6,992 | $4.80 | $33.6K | |
| Feb 21, 2024 | M. Friedberg Ezra | Executive | Option Exercise | 13,649 | $4.80 | $65.5K | |
| Feb 21, 2024 | C. Davis Todd | Executive | Option Exercise | 29,167 | $4.80 | $140.0K | |
| Feb 21, 2024 | M. Friedberg Ezra | Executive | Purchase | 16,667 | $6.00 | $100.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise(M) | 3 | $239.1K | 65.5% |
Purchase(P) | 6 | $125.8K | 34.5% |
Gift(G) | 2 | $0 | 0.0% |
Insiders at Chromocell Therapeutics Corp are accumulating shares at an accelerated pace. With 4 insiders making 11 transactions totaling $125.8K in purchases versus $0 in sales, the net buying activity of $125.8K signals strong executive confidence. Ezra M. Friedberg (Executive) leads the buying activity with $199.1K in transactions across all time.